From Reuters, via Yahoo News: Cash-strapped governments have slashed drug prices, racked up close to $20 billion (12.7 billion pounds) in unpaid bills for treatments and are becoming increasingly reluctant to pay for innovation. So disillusioned drugmakers are cutting back operations in Europe and launching more and more drugs elsewhere – trends that look set … Continue reading